Gudrun Würthwein

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Top Venues

European journal of drug metabolism and pharmacokinetics

Scientific reports

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Han Chien, Gudrun Würthwein, Pablo Zubiaur, Bianca Posocco, María Angeles Pena Pardo, Alberto M Borobia, Sara Gagno, Francisco Abad-Santos, Georg Hempel
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg. Cancer chemotherapy and pharmacology 90 (2) (2022)
Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Stary, Petr Smisek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian Georg Wicha, Joachim Boos, null null
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data. European journal of drug metabolism and pharmacokinetics 46 (2) (2021)
Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten, Petr Smisek, Christa Ellen Nath, Carmelo Rizzari, Joachim Boos, Gudrun Würthwein
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach. European journal of drug metabolism and pharmacokinetics (2021)
Christian Siebel, Claudia Lanvers-Kaminsky, Gudrun Würthwein, Georg Hempel, Joachim Boos
Bioanalysis of doxorubicin aglycone metabolites in human plasma samples-implications for doxorubicin drug monitoring. Scientific reports 10 (1) (2020)